InsidersTradesSigma
Track the 제넥신 share price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares are quoted on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 제넥신 has recorded 1 insider filings. Market capitalisation: €109.8bn. The latest transaction was filed on 11 March 2026 (Other). Among the most active insiders: 제넥신. Every trade is free.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Genexine es una empresa de biotecnología centrada en el desarrollo de fármacos innovadores para el tratamiento de enfermedades autoinmunes y cánceres. Cotiza en el mercado XKRX.